<DOC>
	<DOCNO>NCT00891995</DOCNO>
	<brief_summary>The purpose study find tight blood glucose control onset Type 1 Diabetes preserve beta cell function . Study subject randomly assign receive either standard diabetes management intensive diabetes management , involve several day close loop therapy follow home use continuous glucose monitor insulin pump .</brief_summary>
	<brief_title>Effect Metabolic Control Onset Diabetes Progression Type 1 Diabetes</brief_title>
	<detailed_description>The specific aim study determine early restoration metabolic control improve C-peptide production compare child receive routine diabetes management secondary aim determine allow islet cell less metabolically active impact underlie autoimmune process . Following completion baseline procedure ( Mixed Meal Tolerance Test blood sample collection ) , participant randomize either Standard Treatment Group Intensive Treatment Group include 4-6 day inpatient close loop therapy follow outpatient use insulin pump continuous glucose monitor diabetes management . All subject see 7 time first year 4 time second year follow-up testing . Subjects still produce insulin 2 year may ask return every 6 month additional 2 year .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Age 6.0 &lt; 46.0 year Diagnosis type 1 diabetes initiation insulin therapy within past 7 day ( day 1 first day insulin therapy ) If participant female reproductive potential , willing avoid pregnancy pregnancy test negative . Willing accept randomization either intensive diabetes management group standard care group . Willing complete plan 2 year followup . Able electronically transmit data monthly . Investigator believe participant ( parent/guardian child ) understand agree comply study protocol capable undertaking necessary testing . Currently pregnant lactating , anticipate get pregnant next one year . Currently anemic ( hematocrit level obtain screen visit ) . Chronic use systemic steroid noninsulin pharmaceutical might affect glycemic control presence disease likely treat medication first two year study . Complicating medical issue might interfere study conduct . Inpatient psychiatric treatment past 6 month ( participant minor , either participant participant 's primary care giver ) . Currently participate another type 1 diabetes treatment study , include intervention trial treatment diabetic ketoacidosis .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Type 1 Diabetes</keyword>
	<keyword>Closed Loop Therapy</keyword>
	<keyword>Continuous Glucose Monitor</keyword>
</DOC>